The AIDA and the Extra Laser Systems for Excimer Laser Trabeculotomy Proved Comparable IOP Lowering Efficacy-12-month Results

Overview

Journal Int Ophthalmol

Specialty Ophthalmology

Date 2022 Feb 4

PMID 35119608

Authors

Sufian Hommayda

Timothy Hamann

Marc Toteberg-Harms

Affiliations

Soon will be listed here.

Abstract

Purpose: Cataract surgery combined with excimer laser trabeculotomy (phaco-ELT) leads to a significant reduction in intraocular pressure by enhancing trabecular outflow. The aim of this study is to compare two laser systems for ELT (AIDA vs. ExTra).

Methods: In this retrospective chart review, inclusion criteria were a diagnosis of glaucoma and phaco-ELT between 07/17/2010 and 07/17/2018. Data were collected preoperatively and postoperatively up to 1 year. Success was defined as IOP reduction of ≥ 20% compared to baseline plus an IOP of < 21 mmHg with no hypotony, no loss of light perception vision, and no subsequent glaucoma surgery.

Results: Three hundred and fourteen eyes (mean age 75.9 ± 8.6 years) were included. Baseline intraocular pressure (IOP) for the ExTra group (94 eyes) was 20.3 ± 5.9 mmHg on 2.0 ± 1.3 anti-glaucoma drugs (AGD) and a best-corrected visual acuity (BCVA, logMar) of 0.5 ± 0.4. For The AIDA group (220 eyes), baseline IOP was 18.7 ± 6.3 mmHg on 2.0 ± 1.3 AGD and a BCVA of 0.3 ± 0.3. In the ExTra group, IOP was reduced to 12.8 ± 2.5 mmHg (-37%) and in the AIDA group to 14.7 ± 3.9 (-21%, p = 0.14) at 1 year. AGD reduction in the ExTra group was 1.3 ± 1.5 and 1.8 ± 1.4 in the AIDA group (p = 0.14). Success rates were 80% (ExTra) and 70% (AIDA), respectively (p = 0.552). Thirty-one eyes (10.0%) required a subsequent glaucoma surgery during the follow-up.

Conclusion: Both laser platforms, the ExTra and the AIDA laser, used for Phaco-ELT lead to a significant reduction in intraocular pressure and anti-glaucoma drugs with no statistically significant difference in success rates during the follow-up of 12 months.

Trial Registration Swissethics: 2018-01,791.

References

Vogel M, Lauritzen K . [Selective excimer laser ablation of the trabecular meshwork. Clinical results]. Ophthalmologe. 1997; 94(9):665-7. DOI: 10.1007/s003470050180. View

Jonas J, Aung T, Bourne R, Bron A, Ritch R, Panda-Jonas S . Glaucoma. Lancet. 2017; 390(10108):2183-2193. DOI: 10.1016/S0140-6736(17)31469-1. View

Brandao L, Grieshaber M . Update on Minimally Invasive Glaucoma Surgery (MIGS) and New Implants. J Ophthalmol. 2013; 2013:705915. PMC: 3863473. DOI: 10.1155/2013/705915. View

Chen P, Lin S, Junk A, Radhakrishnan S, Singh K, Chen T . The Effect of Phacoemulsification on Intraocular Pressure in Glaucoma Patients: A Report by the American Academy of Ophthalmology. Ophthalmology. 2015; 122(7):1294-307. DOI: 10.1016/j.ophtha.2015.03.021. View

Toteberg-Harms M, Wachtl J, Schweier C, Funk J, Kniestedt C . Long-term efficacy of combined phacoemulsification plus trabeculectomy versus phacoemulsification plus excimer laser trabeculotomy. Klin Monbl Augenheilkd. 2017; 234(4):457-463. DOI: 10.1055/s-0043-100291. View

Wilmsmeyer S, Philippin H, Funk J . Excimer laser trabeculotomy: a new, minimally invasive procedure for patients with glaucoma. Graefes Arch Clin Exp Ophthalmol. 2005; 244(6):670-6. DOI: 10.1007/s00417-005-0136-y. View

Jozic L, Magner J, Funk J, Toteberg-Harms M . Correction to: Success of combined cataract extraction plus excimer laser trabeculotomy exceeds that of combined ab interno trabeculectomy with the trabectome or cataract extraction alone. Int Ophthalmol. 2020; 40(3):539. DOI: 10.1007/s10792-019-01256-9. View

Carreon T, van der Merwe E, Fellman R, Johnstone M, Bhattacharya S . Aqueous outflow - A continuum from trabecular meshwork to episcleral veins. Prog Retin Eye Res. 2016; 57:108-133. PMC: 5350024. DOI: 10.1016/j.preteyeres.2016.12.004. View

Durr G, Toteberg-Harms M, Lewis R, Fea A, Marolo P, Ahmed I . Current review of Excimer laser Trabeculostomy. Eye Vis (Lond). 2020; 7:24. PMC: 7199329. DOI: 10.1186/s40662-020-00190-7. View

10.

Pache M, Wilmsmeyer S, Funk J . [Laser surgery for glaucoma: excimer-laser trabeculotomy]. Klin Monbl Augenheilkd. 2006; 223(4):303-7. DOI: 10.1055/s-2005-858861. View

11.

Lavia C, Dallorto L, Maule M, Ceccarelli M, Fea A . Minimally-invasive glaucoma surgeries (MIGS) for open angle glaucoma: A systematic review and meta-analysis. PLoS One. 2017; 12(8):e0183142. PMC: 5574616. DOI: 10.1371/journal.pone.0183142. View

12.

Bourne R, Jonas J, Bron A, Cicinelli M, Das A, Flaxman S . Prevalence and causes of vision loss in high-income countries and in Eastern and Central Europe in 2015: magnitude, temporal trends and projections. Br J Ophthalmol. 2018; 102(5):575-585. PMC: 5909755. DOI: 10.1136/bjophthalmol-2017-311258. View

13.

Toteberg-Harms M, Hanson J, Funk J . Cataract surgery combined with excimer laser trabeculotomy to lower intraocular pressure: effectiveness dependent on preoperative IOP. BMC Ophthalmol. 2013; 13:24. PMC: 3724507. DOI: 10.1186/1471-2415-13-24. View

14.

Toteberg-Harms M, Ciechanowski P, Hirn C, Funk J . [One-year results after combined cataract surgery and excimer laser trabeculotomy for elevated intraocular pressure]. Ophthalmologe. 2011; 108(8):733-8. DOI: 10.1007/s00347-011-2337-6. View

15.

ARMALY M, KRUEGER D, Maunder L, Becker B, Hetherington Jr J, Kolker A . Biostatistical analysis of the collaborative glaucoma study. I. Summary report of the risk factors for glaucomatous visual-field defects. Arch Ophthalmol. 1980; 98(12):2163-71. DOI: 10.1001/archopht.1980.01020041015002. View

16.

Deubel C, Bohringer D, Anton A, Reinhard T, Lubke J . Long-term follow-up of intraocular pressure and pressure-lowering medication in patients following Excimer laser trabeculotomy. Graefes Arch Clin Exp Ophthalmol. 2020; 259(4):957-962. PMC: 8016798. DOI: 10.1007/s00417-020-05029-4. View

17.

Richter G, Coleman A . Minimally invasive glaucoma surgery: current status and future prospects. Clin Ophthalmol. 2016; 10:189-206. PMC: 4734795. DOI: 10.2147/OPTH.S80490. View

18.

Babighian S, Caretti L, Tavolato M, Cian R, Galan A . Excimer laser trabeculotomy vs 180 degrees selective laser trabeculoplasty in primary open-angle glaucoma. A 2-year randomized, controlled trial. Eye (Lond). 2009; 24(4):632-8. DOI: 10.1038/eye.2009.172. View

19.

Garway-Heath D, Crabb D, Bunce C, Lascaratos G, Amalfitano F, Anand N . Latanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trial. Lancet. 2014; 385(9975):1295-304. DOI: 10.1016/S0140-6736(14)62111-5. View

20.

Kass M, Heuer D, Higginbotham E, Johnson C, Keltner J, Miller J . The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol. 2002; 120(6):701-13; discussion 829-30. DOI: 10.1001/archopht.120.6.701. View